Watch OLMA. Know when insiders buy.
One email the day a filing lands. Free.
OLMA
Olema Pharmaceuticals, Inc.
7.33
+0.57 +8.43%
USD · close Nov 6
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
52
WATCH · shorts 52
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $641.4MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$204.6MNET CASH —52W 6.41 – 35.83SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Duquesne Family Office (Stanley Druckenmiller) | Guru | #64 | $12.3M | 987K | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
BVF PARTNERS L P/IL and 10 related9.8%
“Item 4 is hereby amended to add the following: Effective October 14, 2026, Dr. Gorjan Hrustanovic resigned from the Board. Dr. Hrustanovic also resigned from the Compensation Committee of the Board and the Science and Technology Committee of the Board. Dr. Hrustanovic's resignation was not the resul…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.